feed,title,long_url,short_url
Benzinga,Safety Board Recommends BioCardia's Heart Failure Cell Therapy To Continue Unchanged,https://benzinga.com/general/biotech/22/02/25599908/safety-board-recommends-biocardias-heart-failure-cell-therapy-to-continue-unchanged,https://bit.ly/3rO707q
Benzinga,Tesla's January Sales In China Slip Back From December's Record: What Investors Need to Know,https://benzinga.com/news/22/02/25598687/teslas-january-sales-in-china-slip-back-from-decembers-record-what-investors-need-to-know,https://bit.ly/34ADSYy
Benzinga,Blue Apron Secures Additional $5M Private Placement Investment,https://benzinga.com/news/22/02/25600878/blue-apron-secures-additional-5m-private-placement-investment,https://bit.ly/34UBGee
